Rapafusyn Pharmaceuticals is an emerging pharmaceutical development company located in Baltimore Maryland. Rapafusyn has licensed technology related to a novel class of natural product-like macrocycles from Johns Hopkins University School of Medicine and seeks to develop novel pharmaceuticals to treat patients having diseases and fulfill unmet medical  needs.

Rapafusyn Pharmaceuticals

Rapafusyn is pleased to announce two presentations at the Drug Discovery Chemistry Meeting, April 1 – 4 in San Diego. Dr. Rick Ewing, VP of Medicinal Chemistry, will be giving an oral presentation on Rapafusyn’s Non-Degradation Molecular Glue platform and Dr. Sam Hong will be presenting a poster on our industry leading libraries of molecular glues. Go to https://lnkd.in/dNkqe6qQ for more details.

Rapafusyn Pharmaceuticals is proud to announce Dr. Rick Ewing, Vice President of Medicinal Chemistry, has been recognized for his outstanding accomplishments with two distinguished awards. Rick has received both the 2023 American Chemical Society (ACS) Philadelphia Section Award, and the 2023 Edison Patent Award in Biotechnology – congratulations Rick! For more information go to https://lnkd.in/eGr94knP


Join us as we share innovative insights, groundbreaking solutions, and a vision for the future! 


Rapafusyn is thrilled to announce two presentations at the upcoming Molecular Glue Drug Discovery Summit, Jan 31 – Feb 1 in Boston. Dr. Rick Ewing, VP of Medicinal Chemistry, will be giving an oral presentation on Rapafusyn’s Non-Degradation Molecular Glue platform and Dr. Matthew Olson will be presenting a poster on our ENT1 program for the treatment of Acute Kidney Injury. Go to https://lnkd.in/dNkqe6qQ for more details.

Fortress Biotech is a pharmaceutical company focused on acquiring, developing, and commercializing novel pharmaceutical and biotechnology products.

Fortress Biotech

Assertio is a pharmaceutical company that develops and markets prescription and over-the-counter pharmaceutical products.

Assertio

Aptuit is a pharmaceutical services company offering a wide range of drug development and manufacturing services.

Aptuit

Bioiberica is a biotechnology company specializing in the research, development, production, and marketing of biomolecules for the pharmaceutical, nutraceutical, veterinary, and agricultural industries.

Bioiberica

Hudson Therapeutics is a biopharmaceutical company focused on developing novel therapies for various diseases.

Hudson Therapeutics

Nanobots Therapeutics is a company specializing in the development of nanotechnology-based therapies for medical applications.

Nanobots Therapeutics

Shinobi Therapeutics is a biotechnology company focused on the discovery and development of novel treatments for various diseases.

Shinobi Therapeutics

Rapafusyn is a company that appears to specialize in technology solutions. The name suggests a focus on rapid fusion of technology and data to provide innovative services or products.

Rapafusyn

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Jun 22, 2024 12:45 PM	9d061ac1
public peers	general	Jun 21, 2024 4:43 PM	4705d227
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 21, 2024 4:45 PM	aca38b8a
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jun 21, 2024 4:43 PM	0d801f97
translate crunchbase fundingrounds	general
peers	general
news basic	general	Jun 21, 2024 4:43 PM	e438d3bc
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:RAPAFUSYN

Rapafusyn